Study of Lumateperone for Autism-Related Irritability in Teens
Part of Mental health clinical trials.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 13 and 17 years old (the study is currently enrolling teens)
- You need a parent or legal guardian who can come to all study visits and help the team take care of you
- You must have a diagnosis of autism spectrum disorder (ASD) and have noticeable irritability
- You should not have another major psychiatric diagnosis, except for ADHD if you are on stable medication
- You cannot have Rett syndrome, Fragile X syndrome, or be at immediate risk of harming yourself
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, KarXT, to see if it can help reduce irritability in children and teenagers with autism. It aims to improve symptoms like anger, aggression, and mood swings.
This study tests an investigational medication called lumateperone to see if it can reduce irritability in children and teens with autism. It is for teenagers aged 13–17 whose irritability is causing significant problems.
This study tests a new medication to help reduce irritability in children and teenagers with autism spectrum disorder. The medication may improve mood and behavior, making daily life easier for the child and family.
This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
This trial tests a medication called lumateperone to see if it can improve apathy (lack of motivation) in people who have psychotic symptoms from schizophrenia or related disorders. It may help if you are already on a stable treatment but still struggle with apathy.
Hear when a new Irritability Associated With Autism Spectrum Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.